Company registration number SC461389 (Scotland)
EJF MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
EJF MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
EJF MEDICAL LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
-
0
211
Current assets
Debtors
4
-
0
6,350
Cash at bank and in hand
78
18,303
78
24,653
Creditors: amounts falling due within one year
Other creditors
1,260
38,516
Net current liabilities
(1,182)
(13,863)
Net liabilities
(1,182)
(13,652)
Capital and reserves
Called up share capital
6
100
100
Profit and loss reserves
(1,282)
(13,752)
Total equity
(1,182)
(13,652)

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 12 May 2026 and are signed on its behalf by:
Ms E Ferguson
Director
Company registration number SC461389 (Scotland)
EJF MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 2 -
1
Accounting policies
Company information

EJF Medical Limited is a private company limited by shares incorporated in Scotland. The registered office is 3 Wellington Square, Ayr, Ayrshire, United Kingdom, KA7 1EN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

On 31 March 2025, EJF Medical Limited ceased trading. The directors have resolved to wind up the company and consider it inappropriate to prepare the accounts on a going concern basis. Therefore, the directors have prepared these financial statements on a break-up basis, as set out under the basis of preparation.true

1.3
Turnover

The Turnover shown in the profit and loss account represents revenue recognised by the company in respect of medical services supplied during the period.

1.4
Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and equipment
Straight Line over 3 years
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
5
EJF MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 3 -
3
Tangible fixed assets
Computer Equipment
£
Cost
At 1 November 2024
2,796
Disposals
(2,796)
At 31 October 2025
-
0
Depreciation and impairment
At 1 November 2024
2,585
Eliminated in respect of disposals
(2,585)
At 31 October 2025
-
0
Carrying amount
At 31 October 2025
-
0
At 31 October 2024
211
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
-
0
6,350
5
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
1,260
38,516
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100
7
Related party transactions

During the year, consultancy income of £2,270 (2024: £5,480) was received from ABC4D Ltd, a company in which the director, E J Ferguson, is also a director and shareholder.

During the year, management charges of £12,000 (2024: £nil) were received from E Stewart Medic Ltd, a company in which the director, E J Ferguson, is also a director and shareholder.

2025-10-31 2024-11-01 false false false 12 May 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Ms E Ferguson Mr J Ferguson SC461389 2024-11-01 2025-10-31 SC461389 2025-10-31 SC461389 2024-10-31 SC461389 core:ComputerEquipment 2025-10-31 SC461389 core:ComputerEquipment 2024-10-31 SC461389 core:WithinOneYear 2025-10-31 SC461389 core:WithinOneYear 2024-10-31 SC461389 core:CurrentFinancialInstruments 2025-10-31 SC461389 core:CurrentFinancialInstruments 2024-10-31 SC461389 core:ShareCapital 2025-10-31 SC461389 core:ShareCapital 2024-10-31 SC461389 core:RetainedEarningsAccumulatedLosses 2025-10-31 SC461389 core:RetainedEarningsAccumulatedLosses 2024-10-31 SC461389 core:ShareCapitalOrdinaryShareClass1 2025-10-31 SC461389 core:ShareCapitalOrdinaryShareClass1 2024-10-31 SC461389 bus:Director1 2024-11-01 2025-10-31 SC461389 core:PlantMachinery 2024-11-01 2025-10-31 SC461389 2023-11-01 2024-10-31 SC461389 core:ComputerEquipment 2024-10-31 SC461389 core:ComputerEquipment 2024-11-01 2025-10-31 SC461389 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 SC461389 bus:OrdinaryShareClass1 2025-10-31 SC461389 bus:OrdinaryShareClass1 2024-10-31 SC461389 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 SC461389 bus:FRS102 2024-11-01 2025-10-31 SC461389 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 SC461389 bus:Director2 2024-11-01 2025-10-31 SC461389 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 SC461389 bus:FullAccounts 2024-11-01 2025-10-31 xbrli:pure xbrli:shares iso4217:GBP